Acea biosciences:1105804 [18-020797]

Ended Purchase Order Awarded Last action

Contract number
HHSN261201800189P
Awardee
Awarding agency
Obligated
$22,504

Award facts

Contract value 100% obligated
$22,504.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a purchase order to Acea Biosciences, Inc. for $22,504.00 on March 1, 2018, with a completion date of August 31, 2018. The order is a firm fixed price, commercial acquisition with no small business set-aside. Performance takes place in Bethesda, Maryland. The procurement covers specialized life sciences equipment, instrumentation, or related services aligned with Acea's portfolio of flow cytometry, cell analysis, and biosensing products for research support.

Quick answers

Who was awarded contract HHSN261201800189P?

HHSN261201800189P was awarded to Acea Biosciences, Inc. by National Cancer Institute (National Institutes of Health) on March 1, 2018.

How much is contract HHSN261201800189P worth?

The government has obligated $22,504 on HHSN261201800189P.

Was contract HHSN261201800189P competed?

The extent of competition for HHSN261201800189P was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award